Cargando…
First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age
CONTEXT: Prenatal treatment of human disease is rare. Dexamethasone (DEX) is used in pregnancies at risk for congenital adrenal hyperplasia (CAH) to prevent virilization in an affected female fetus. The safety and long-term consequences of prenatal DEX exposure on the brain are largely unknown. OBJE...
Autores principales: | van’t Westeinde, Annelies, Karlsson, Leif, Nordenström, Anna, Padilla, Nelly, Lajic, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304558/ https://www.ncbi.nlm.nih.gov/pubmed/32497228 http://dx.doi.org/10.1210/clinem/dgaa340 |
Ejemplares similares
-
First Trimester Dexamethasone Treatment Is Not Associated With Alteration in Resting-state Connectivity at Adolescent or Adult Age
por: Messina, Valeria, et al.
Publicado: (2022) -
First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults
por: van’t Westeinde, Annelies, et al.
Publicado: (2020) -
Ambulatory Blood Pressure Monitoring in Children and Adults Prenatally Exposed to Dexamethasone Treatment
por: Karlsson, Leif, et al.
Publicado: (2022) -
Changes in resting-state functional connectivity in patients with congenital adrenal hyperplasia
por: Messina, Valeria, et al.
Publicado: (2022) -
Perturbed Beta-Cell Function and Lipid Profile After Early Prenatal Dexamethasone Exposure in Individuals Without CAH
por: Wallensteen, Lena, et al.
Publicado: (2020)